---
pmid: '24190013'
title: Genome-wide association study of subtype-specific epithelial ovarian cancer
  risk alleles using pooled DNA.
authors:
- Earp MA
- Kelemen LE
- Magliocco AM
- Swenerton KD
- Chenevix-Trench G
- Australian Cancer Study
- Australian Ovarian Cancer Study Group
- Lu Y
- Hein A
- Ekici AB
- Beckmann MW
- Fasching PA
- Lambrechts D
- Despierre E
- Vergote I
- Lambrechts S
- Doherty JA
- Rossing MA
- Chang-Claude J
- Rudolph A
- Friel G
- Moysich KB
- Odunsi K
- Sucheston-Campbell L
- Lurie G
- Goodman MT
- Carney ME
- Thompson PJ
- Runnebaum IB
- Dürst M
- Hillemanns P
- Dörk T
- Antonenkova N
- Bogdanova N
- Leminen A
- Nevanlinna H
- Pelttari LM
- Butzow R
- Bunker CH
- Modugno F
- Edwards RP
- Ness RB
- du Bois A
- Heitz F
- Schwaab I
- Harter P
- Karlan BY
- Walsh C
- Lester J
- Jensen A
- Kjær SK
- Høgdall CK
- Høgdall E
- Lundvall L
- Sellers TA
- Fridley BL
- Goode EL
- Cunningham JM
- Vierkant RA
- Giles GG
- Baglietto L
- Severi G
- Southey MC
- Liang D
- Wu X
- Lu K
- Hildebrandt MA
- Levine DA
- Bisogna M
- Schildkraut JM
- Iversen ES
- Weber RP
- Berchuck A
- Cramer DW
- Terry KL
- Poole EM
- Tworoger SS
- Bandera EV
- Chandran U
- Orlow I
- Olson SH
- Wik E
- Salvesen HB
- Bjorge L
- Halle MK
- van Altena AM
- Aben KK
- Kiemeney LA
- Massuger LF
- Pejovic T
- Bean YT
- Cybulski C
- Gronwald J
- Lubinski J
- Wentzensen N
- Brinton LA
- Lissowska J
- Garcia-Closas M
- Dicks E
- Dennis J
- Easton DF
- Song H
- Tyrer JP
- Pharoah PD
- Eccles D
- Campbell IG
- Whittemore AS
- McGuire V
- Sieh W
- Rothstein JH
- Flanagan JM
- Paul J
- Brown R
- Phelan CM
- Risch HA
- McLaughlin JR
- Narod SA
- Ziogas A
- Anton-Culver H
- Gentry-Maharaj A
- Menon U
- Gayther SA
- Ramus SJ
- Wu AH
- Pearce CL
- Pike MC
- Dansonka-Mieszkowska A
- Rzepecka IK
- Szafron LM
- Kupryjanczyk J
- Cook LS
- Le ND
- Brooks-Wilson A
- Ovarian Cancer Association Consortium
journal: Hum Genet
year: '2014'
full_text_available: false
pmcid: PMC4063682
doi: 10.1007/s00439-013-1383-3
---

# Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
**Authors:** Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Australian Cancer Study, Australian Ovarian Cancer Study Group, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, Lambrechts S, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Friel G, Moysich KB, Odunsi K, Sucheston-Campbell L, Lurie G, Goodman MT, Carney ME, Thompson PJ, Runnebaum IB, Dürst M, Hillemanns P, Dörk T, Antonenkova N, Bogdanova N, Leminen A, Nevanlinna H, Pelttari LM, Butzow R, Bunker CH, Modugno F, Edwards RP, Ness RB, du Bois A, Heitz F, Schwaab I, Harter P, Karlan BY, Walsh C, Lester J, Jensen A, Kjær SK, Høgdall CK, Høgdall E, Lundvall L, Sellers TA, Fridley BL, Goode EL, Cunningham JM, Vierkant RA, Giles GG, Baglietto L, Severi G, Southey MC, Liang D, Wu X, Lu K, Hildebrandt MA, Levine DA, Bisogna M, Schildkraut JM, Iversen ES, Weber RP, Berchuck A, Cramer DW, Terry KL, Poole EM, Tworoger SS, Bandera EV, Chandran U, Orlow I, Olson SH, Wik E, Salvesen HB, Bjorge L, Halle MK, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean YT, Cybulski C, Gronwald J, Lubinski J, Wentzensen N, Brinton LA, Lissowska J, Garcia-Closas M, Dicks E, Dennis J, Easton DF, Song H, Tyrer JP, Pharoah PD, Eccles D, Campbell IG, Whittemore AS, McGuire V, Sieh W, Rothstein JH, Flanagan JM, Paul J, Brown R, Phelan CM, Risch HA, McLaughlin JR, Narod SA, Ziogas A, Anton-Culver H, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Wu AH, Pearce CL, Pike MC, Dansonka-Mieszkowska A, Rzepecka IK, Szafron LM, Kupryjanczyk J, Cook LS, Le ND, Brooks-Wilson A, Ovarian Cancer Association Consortium
**Journal:** Hum Genet (2014)
**DOI:** [10.1007/s00439-013-1383-3](https://doi.org/10.1007/s00439-013-1383-3)
**PMC:** [PMC4063682](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063682/)

## Abstract

1. Hum Genet. 2014 May;133(5):481-97. doi: 10.1007/s00439-013-1383-3. Epub 2013
Nov  5.

Genome-wide association study of subtype-specific epithelial ovarian cancer risk 
alleles using pooled DNA.

Earp MA(1), Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G; 
Australian Cancer Study; Australian Ovarian Cancer Study Group; Lu Y, Hein A, 
Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, 
Lambrechts S, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Friel G, 
Moysich KB, Odunsi K, Sucheston-Campbell L, Lurie G, Goodman MT, Carney ME, 
Thompson PJ, Runnebaum IB, Dürst M, Hillemanns P, Dörk T, Antonenkova N, 
Bogdanova N, Leminen A, Nevanlinna H, Pelttari LM, Butzow R, Bunker CH, Modugno 
F, Edwards RP, Ness RB, du Bois A, Heitz F, Schwaab I, Harter P, Karlan BY, 
Walsh C, Lester J, Jensen A, Kjær SK, Høgdall CK, Høgdall E, Lundvall L, Sellers 
TA, Fridley BL, Goode EL, Cunningham JM, Vierkant RA, Giles GG, Baglietto L, 
Severi G, Southey MC, Liang D, Wu X, Lu K, Hildebrandt MA, Levine DA, Bisogna M, 
Schildkraut JM, Iversen ES, Weber RP, Berchuck A, Cramer DW, Terry KL, Poole EM, 
Tworoger SS, Bandera EV, Chandran U, Orlow I, Olson SH, Wik E, Salvesen HB, 
Bjorge L, Halle MK, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, 
Bean YT, Cybulski C, Gronwald J, Lubinski J, Wentzensen N, Brinton LA, Lissowska 
J, Garcia-Closas M, Dicks E, Dennis J, Easton DF, Song H, Tyrer JP, Pharoah PD, 
Eccles D, Campbell IG, Whittemore AS, McGuire V, Sieh W, Rothstein JH, Flanagan 
JM, Paul J, Brown R, Phelan CM, Risch HA, McLaughlin JR, Narod SA, Ziogas A, 
Anton-Culver H, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Wu AH, Pearce 
CL, Pike MC, Dansonka-Mieszkowska A, Rzepecka IK, Szafron LM, Kupryjanczyk J, 
Cook LS, Le ND, Brooks-Wilson A; Ovarian Cancer Association Consortium.

Author information:
(1)Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 
10th Avenue, Vancouver, BC, V5Z 1L3, Canada, mearp@bcgsc.ca.

Epithelial ovarian cancer (EOC) is a heterogeneous cancer with both genetic and 
environmental risk factors. Variants influencing the risk of developing the 
less-common EOC subtypes have not been fully investigated. We performed a 
genome-wide association study (GWAS) of EOC according to subtype by pooling 
genomic DNA from 545 cases and 398 controls of European descent, and testing for 
allelic associations. We evaluated for replication 188 variants from the GWAS 
[56 variants for mucinous, 55 for endometrioid and clear cell, 53 for 
low-malignant potential (LMP) serous, and 24 for invasive serous EOC], selected 
using pre-defined criteria. Genotypes from 13,188 cases and 23,164 controls of 
European descent were used to perform unconditional logistic regression under 
the log-additive genetic model; odds ratios (OR) and 95 % confidence intervals 
are reported. Nine variants tagging six loci were associated with 
subtype-specific EOC risk at P < 0.05, and had an OR that agreed in direction of 
effect with the GWAS results. Several of these variants are in or near genes 
with a biological rationale for conferring EOC risk, including ZFP36L1 and 
RAD51B for mucinous EOC (rs17106154, OR = 1.17, P = 0.029, n = 1,483 cases), 
GRB10 for endometrioid and clear cell EOC (rs2190503, P = 0.014, n = 2,903 
cases), and C22orf26/BPIL2 for LMP serous EOC (rs9609538, OR = 0.86, P = 0.0043, 
n = 892 cases). In analyses that included the 75 GWAS samples, the association 
between rs9609538 (OR = 0.84, P = 0.0007) and LMP serous EOC risk remained 
statistically significant at P < 0.0012 adjusted for multiple testing. 
Replication in additional samples will be important to verify these results for 
the less-common EOC subtypes.

DOI: 10.1007/s00439-013-1383-3
PMCID: PMC4063682
PMID: 24190013 [Indexed for MEDLINE]
